Search
for
Sort by
Research 121–150 of 133
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Functionalized Bacterial Cellulose for Medical Tissue Engineering
- Cardiovascular Risks in Women with Polycystic Ovary Syndrome (PCOS): A Narrative Review
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- Benefits of Testosterone Replacement and Methods of Substitution
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Hormonal contraceptives: pharmacology tailored to women's health
- Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis
- Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
- Gender-Affirming Hormone Therapy for Transgender Females
- Is hormonal treatment still an option in acne today?
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation
- Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data
- 52309 Association of venous thromboembolism in patients with alopecia areata
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Contraceptive implants considered 'safe'
- Combined hormonal contraception and venous thromboembolism
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- Alopecia areata does not increase the risk of venous thromboembolism: an All of Us case-control study
- Venous thromboembolism and women's health